Nucleic Acid Therapeutics

Impact Factor: 4

Coeditors-in-Chief: Bruce A. Sullenger, PhD<br>and Annemieke Aartsma-Rus, PhD

Society Affiliation: Oligonucleotide Therapeatics Society

Description:

As the leading journal in its field, this journal focuses on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. The journal examines many new approaches for using nucleic acids as therapeutic agents or in modifying nucleic acids for clinical purposes, including: oligonucleotides, gene modification, aptamers, RNA nanoparticles, and ribozymes.